A 55-year-old woman developed alopecia areata (AA) approximately one year after starting treatment with upadacitinib for atopic dermatitis, as described in this case report. This occurrence suggests a potential link between upadacitinib and drug-induced AA, a connection not previously documented in the literature. The case underscores the need for further investigation into whether upadacitinib can cause AA, highlighting the typical timeline for drug-induced alopecia.
Eli Lilly's drug baricitinib showed effectiveness in treating alopeciaareata, with higher doses resulting in significant hair regrowth compared to placebo. The treatment is not for male pattern baldness.
Baricitinib, approved for alopeciaareata, might be considered for treating receding hairlines. The discussion is about the possibility of an over-the-counter topical version for androgenic alopecia.
In this conversation, 4990 discussed various treatments for hair loss, including oral minoxidil, PRP, transplan, Jak inhibitors, Dutasteride, Finasteride, Olumiant, Ketoconazole, RU58841, microneedling, baricitinib, and CCCA. They recommended scalp biopsies in unclear cases of DUPA, twice weekly to twice daily shampooing for topical minoxidil users, and two sessions spaced one month apart with follow up at month three to determine the effectiveness of PRP treatment.
The user is experiencing diffuse thinning and inflammation despite using 2.5mg dutasteride daily, ciclopirox, and ketoconazole shampoos. They are considering treatments like hydroxychloroquine and JAK inhibitors due to suspected scarring alopecia and have faced challenges in obtaining a scalp biopsy.
A user with alopecia totalis, borderline universalis, seeks advice on getting into a Xeljanz trial or appealing insurance for coverage. They experienced significant hair regrowth but are now seeing hair loss again and want to try Xeljanz.
The user suspects scarring alopecia and is exploring NSAIDs and turmeric/pepper for inflammation-related hair loss, having experienced burning and thinning with finasteride and testosterone reduction. They are seeking feedback while unable to afford a dermatologist.
